Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Common carotid artery intima-media thickness increases throughout the pregnancy cycle: a prospective cohort study

  • 1, 2Email authorView ORCID ID profile,
  • 1,
  • 1, 3, 4,
  • 1,
  • 1,
  • 1, 3, 4, 5,
  • 1,
  • 1 and
  • 1
BMC Pregnancy and Childbirth201818:195

https://doi.org/10.1186/s12884-018-1841-y

  • Received: 9 February 2018
  • Accepted: 22 May 2018
  • Published:
Open Peer Review reports

Abstract

Background

High parity is associated with greater cardiovascular disease (CVD) among mid-life and older women. Prospective studies of arterial change throughout pregnancy are needed to provide insight into potential mechanisms. This study assessed vascular adaptation across pregnancy in healthy first-time pregnant women.

Methods

The Maternal Vascular Adaptation to Healthy Pregnancy Study (Pittsburgh, PA, 2010–2015) assessed 37 primigravid women each trimester, 6–8 weeks after delivery and 1–5 years postpartum, with B-mode ultrasound imaging of common carotid artery (CCA) intima-media thickness (IMT) and inter-adventitial diameter (IAD) to assess associations with physical and cardiometabolic measures.

Results

Thirty-seven women (age 28.2 ± 4.5 years, pre-pregnant BMI 24.4 ± 3.2 kg/m2) experienced uncomplicated pregnancies. After adjustment for age and pre-pregnancy BMI, mean (SE) IAD (mm) increased each trimester, from 6.38 (0.08) in the 1st trimester to 6.92 (0.09) in the 3rd trimester, and then returned to 1st trimester levels postpartum (6.35 [0.07], P <  0.001). In contrast, mean (SE) CCA IMT (mm) increased from the 2nd trimester (i.e., 0.546 [0.01]) onward, and remained higher at an average of 2.7 years postpartum (0.581 [0.02], P = 0.03). Weight partially explained changes in IAD.

Conclusions

In uncomplicated first pregnancies, IAD increased and returned to 1st trimester levels postpartum. In contrast, CCA IMT remained increased 2 years postpartum. Maternal weight explained vascular changes better than did metabolic changes. Increased postpartum CCA IMT may persist and contribute to long-term CVD risk.

Keywords

  • Common carotid artery intima-media thickness
  • Inter-adventitial diameter
  • Pregnancy
  • Cardiovascular disease
  • Vascular remodeling

Background

High parity is associated with greater cardiovascular disease (CVD) risk in women [1]. Although some of this risk may be due to socio-economic status and lifestyle factors associated with greater parity, acute physiologic changes during pregnancy also may contribute to CVD risk [14]. For example, either weight gain or the atherogenic metabolic changes of pregnancy may instigate persistent unhealthy vascular changes [5, 6]. However, studies that could illuminate these relationships have been limited by 1) sample sizes inadequate to detect significant differences in vessel measures [7, 8], 2) failure to collect serial arterial measures [6], 3) use of non-standard techniques to assess the vasculature [5, 9], 4) short follow-up [7, 8], and 5) lack of biomarker collection across the pregnancy cycle [510].

Structural arterial changes during pregnancy can be assessed using B-mode ultrasonography of the carotid artery, a well-established, non-invasive, reproducible technique [11]. Abnormal values of two measures of arterial structure—greater intima-media thickness (IMT) and inter-adventitial diameter (IAD) of the common carotid artery (CCA)—are associated with greater CVD risk factor burden [1214], arterial aging [15], and higher incidence of CVD [13, 16, 17]. The normal changes that occur in the CCA IMT and IAD during and after a healthy pregnancy have not been well established.

The primary objective of our Maternal Vascular Adaptation to Healthy Pregnancy (MVP) study was to assess vascular changes in normal first pregnancies, using an adequate sample size, serial measures, a standardized technique to assess vasculature, and including collection of biomarkers. We hypothesized that the vasculature would transiently adapt to the increased blood volume and metabolic requirements of healthy pregnancy, and that these adaptations would be associated with pregnancy weight gain and changes in levels of cardiometabolic factors.

Methods

Study design and population

The MVP study prospectively assessed common carotid artery measures in a cohort of healthy primigravid women. Eligible participants recruited from the community were healthy, non-smoking primigravid women, aged ≤40 years, at less than 38 weeks of gestational age. Exclusion criteria were the following: 1) vasoactive medication use; 2) infertility history—defined as either experiencing a period of at least 12 months marked by the inability to achieve pregnancy or using fertility medications to achieve pregnancy; 3) family history of premature coronary artery disease; 4) previous abortion; 5) multiple gestation.

Study visits were scheduled at 12–14, 24–26, and 36–38 weeks of pregnancy, and 6–8 weeks postpartum; all visits were conducted between in 2010 to 2013. After telephone screening for eligibility, women began the study at any one of the pregnancy visits. Each visit involved physical measures (e.g., height and weight) and ultrasound measures of the carotid artery. We calculated that 31 women were needed as participants to generate 80% power to detect a 0.5 SD difference for change in CCA IMT and IAD given an assumed 0.5 correlation among the repeated observations. Because we estimated that 1) 10–20% of women develop a pregnancy complication and 2) our study would experience 25% attrition, we targeted recruitment of 46. The study enrolled 44 women, of whom 43 had multiple visits, and six developed pregnancy complications (one preeclampsia; 3 gestational hypertension; 2 preterm births, one of which had a placental abruption), which left 37 participants with uncomplicated pregnancies and full term births of normal weight newborns in the analytic sample for our analysis.

These participants were invited to return for a follow-up visit 1–5 years after their first postpartum visit. Fourteen had moved out of the region and were unable to participate. Participants (i.e., five women) were excluded if they were pregnant or if they had given birth within the previous 4 months, which generated seventeen potential participants. Of these seventeen, fourteen experienced uncomplicated first pregnancies and were, therefore, included in our analysis. These follow-up visits occurred between 2014 and 2015. Participants signed an informed consent document approved by the University of Pittsburgh, Human Research Protection Office.

Carotid artery measures

Carotid ultrasounds were performed by a trained research vascular sonographer from the University of Pittsburgh, Ultrasound Research Laboratory (URL). Participants were placed supine, with a right hip wedge for comfort if necessary, and the common carotid artery was scanned bilaterally with high-resolution B-mode ultrasound (ACUSON Cypress System, Malvern, PA.) Digitized images of the common carotid artery were obtained at end diastole, 1 cm proximal to the carotid bulb, and IMT was measured as the distance from the media-adventitial interface to the intima-lumen interface of both the near and far wall of the artery. Approximately 140 measurements of thickness were made for each 1-cm segment, and the mean of each segment was calculated. IMT reported represents the mean value for near and far wall bilaterally. IAD was measured as distance from the adventitial-medial interface of the near arterial wall to the media-adventitial interface of the arterial wall using the same CCA segment. Images were read by one reader, using a computerized, semi-automated reading program system [18]. Reproducibility of carotid measures at the URL was excellent during the time period of the study, with an intraclass correlation coefficient within reader of over 0.91 for CCA IMT and over 0.99 for IAD.

Demographic, pregnancy history, physical, and laboratory measures

At the initial visit, participants completed a self-administered demographic form. Research staff 1) measured the height of participants using a stadiometer and 2) weighed the participants on a standard balance scale. The mean value of two readings for each measure was recorded. Pre-pregnancy weight was identified preferentially as the pre-pregnancy weight documented in the prenatal record or, if not available, as a documented weight in the medical record in the 3 months prior to the last menstrual period. Pre-pregnancy BMI was calculated as pre-pregnancy weight in kilograms divided by height in meters, squared. Weight change was calculated as the difference between current and pre-pregnancy weight.

Pulse and blood pressure were measured, according to a standardized protocol. Three measurements of each were taken, and the mean of the last two measurements was recorded and used for our analysis. Data resulting from both demographic and physical measures and records reviews were collected and managed using REDCap electronic data capture tools hosted at the University of Pittsburgh [19].

Laboratory assays of fasting serum samples collected at each visit were performed at the Heinz Nutrition Laboratory at the University of Pittsburgh, Graduate School of Public Health, and the following parameters were determined using standard laboratory procedures: total cholesterol, high density lipoprotein (HDL-c), low density lipoprotein (LDL-c) [20], triglycerides [21], and glucose [22]. Insulin was measured using a standard radio-immune assay (Linco Research, St. Charles, MO). HOMA-IR, a measure of insulin resistance, was calculated as (glucose (mg/dl) x insulin (μU/ml))/405 [23]. High-sensitivity C-reactive protein (hsCRP) was measured with an enzyme-linked immunoassay (Alpha Diagnostics International Inc., San Antonio, TX).

Prenatal and birth records were reviewed after the first postpartum study visit to exclude women with complications, which included gestational hypertension, preeclampsia, and preterm birth. Participants completed an interval reproductive and health history form at the second postpartum visit.

Statistical analysis

Measures with normal distributions were evaluated as means ± standard deviations. Measures with non-normal distributions (i.e., hsCRP and HOMA-IR) were analyzed as medians with interquartile range and log-transformed for our analysis. Categorical variables (e.g., employment) were presented as percentages. Linear mixed models featuring random intercepts and Toeplitz variance and covariance structure were used to estimate means for CCA IMT and IAD.

Baseline maternal age and pre-pregnancy BMI were included a priori in all models. Separate models were constructed for systolic blood pressure, weight, and weight change. For CCA IMT, models were also constructed including IAD, since over time increases in IAD can cause increases in CCA IMT. Predictors with a significance level of P ≤ 0.2 were then placed into models together, and predictors with a significance level of P ≤ 0.1 were retained. Next, biomarkers were tested individually in the final models identified for each outcome. Biomarkers with a significance level of P ≤ 0.1 were then placed into the best models together, and significant predictors were retained. A sensitivity analysis was performed to eliminate three extreme outlier values for hsCRP (i.e. ≥ 60 mg/L). P values of 0.05 or less were considered statistically significant for the analysis. As a sensitivity analysis, the analysis was repeated using only data from women who completed all four initial visits. Associations between physical and carotid measures were not assessed for the second postpartum visit because 1) associations may differ during pregnancy as a result of dramatic hematologic and hormonal changes and 2) the sample size was smaller (i.e., 14) for this visit. Statistical analyses were performed using SAS statistical software releases 9.3 and 9.4 (SAS Institute, Cary, NC).

Results

The mean number of initial study visits was 3.3 (range 2–4), and 15 participants (41%) completed all 4 visits. The average participant age was 28.4 ± 4.6 years, and the average participant pre-pregnancy BMI was 24.3 ± 3.3. Participants were predominantly white (91.9%), married or living as married (89.2%), well-educated (89.1% college graduate or greater), and employed (64.9% full-time; 24.3% part-time). Mean birth weight was 3427.2 ± 224.5 g and mean gestational age at birth was 39.7 ± 1.3 weeks. Route of birth was vaginal for 91.2% of women, and no newborns had apgar scores less than 7 at 1 or 5 min of life. At the 6–8-week postpartum visit, 88% of participants were breastfeeding their infants exclusively. Fourteen participants completed the second postpartum visit 1–5 years (mean 2.7 years) after their first birth, and seven of these participants had experienced subsequent pregnancies (i.e., five participants reported having one additional birth, one participant reported having two additional births, and one participant having a spontaneous abortion).

Among the participants, IAD increased throughout pregnancy from a mean (SE) of 6.47 (.12) mm in the 1st trimester to 6.89 (.10) mm in the 3rd trimester (all P <  0.05). IAD then returned to early pregnancy values (i.e., 6.36 [.07] mm, P = 0.76) by the first postpartum visit, and we observed no further decrease at the second postpartum visit (6.42 [0.11] mm) (Table 1). Adjustment for maternal age and pre-pregnancy BMI minimally affected these estimates (Fig. 1). CCA IMT remained stable between the 1st and 2nd trimesters and then increased in the 3rd trimester and through the postpartum period (i.e., 1st trimester mean [SE] 0.547 [.02] mm, first postpartum 0.565 [.01] mm, second postpartum 0.581 [0.02] mm) (Table 1). These values changed minimally when adjusted for maternal age and pre-pregnancy BMI (Fig. 2).
Table 1

Unadjusted values for vascular measures and biomarkers by trimester and postpartum

Measure

1st trimester

n = 17

2nd trimester

n = 32

3rd trimester

n = 37

1st postpartum

n = 35

2nd postpartum

n = 14

Overall

P-value

Inter-adventitial diameter (mm)

6.47 (0.12)

6.79 (0.08)

6.89 (0.10)

6.36 (0.07)

6.42 (0.11)

<  0.0001

CCA intima-media thickness (mm)

0.547 (0.02)

0.546 (0.01)

0.553 (0.01)

0.565 (0.01)

0.581 (0.02)

0.03

Weight (kg)

68.7 (2.2)

73.1 (1.6)

79.5 (1.8)

69.2 (1.5)

70.2 (1.9)

<  0.0001

Weight change (kg)

0.55 (0.46)

7.27 (0.62)

14.4 (0.91)

4.3 (0.75)

3.7 (1.1)

<  0.0001

Systolic blood pressure (mm Hg)

103.7 (2.1)

106.0 (1.7)

110.4 (1.4)

106.2 (1.7)

102.9 (2.5)

<  0.0001

Heart rate (bpm)

78.0 (2.4)

79.8 (1.6)

82.0 (1.5)

68.1 (1.5)

63.6 (2.5)

<  0.0001

Total cholesterol (mg/dl)

201.7 (8.9)

257.3 (7.0)

273.1 (7.2)

191.4 (5.5)

194.8 (8.4)

<  0.0001

LDL-c (mg/dl)

111.2 (7.0)

148.0 (6.3)

155.5 (6.6)

114.7 (4.8)

121.9 (7.0)

<  0.0001

Triglycerides (mg/dl)

108.3 (10.5)

176.5 (10.2)

250.7 (13.6)

77.3 (7.0)

87.1 (9.6)

<  0.0001

HDL-c (mg/dl)

68.8 (2.2)

74.0 (3.1)

66.8 (2.3)

61.2 (1.8)

55.6 (2.9)

<  0.0001

Glucose (mg/dl)

79.3 (1.5)

77.2 (1.1)

77.0 (1.2)

82.6 (1.2)

88.5 (1.9)

<  0.0001

Insulin (μU/ml)

8.84 (0.78)

11.25 (0.98)

11.95 (0.81)

8.59 (0.50)

10.76 (0.82)

0.0008

HOMA-IR

1.64 [1.32, 2.09]

2.16 [1.56, 2.56]

2.28 [1.67, 2.51]

1.72 [1.34, 2.13]

2.20 [1.76, 2.87]

0.03

hsCRP (mg/L)

3.58 [2.16, 5.57]

3.36 [2.31, 5.49]

3.29 [2.24, 7.01]

1.20 [.77, 2.44]

0.96 [0.37, 1.50]

<  0.0001

Normally distributed values presented as mean (SE) and P value from mixed models. Skewed values presented as median [IQR] and P-value from Wilcoxon rank-sum test. CCA is common carotid artery. Weight change is change from pre-pregnancy weight

Fig. 1
Fig. 1

Changes in inter-adventitial diameter across pregnancy, adjusted for maternal age and pre-pregnancy BMI. All pairwise comparisons significant at P < .0001 except: 1st Trimester vs. 1st Postpartum P = .0.99, 1st Trimester vs. 2nd Postpartum P = 0.80, 2nd Trimester vs. 3rd Trimester P = .03, 1st postpartum vs. 2nd postpartum P = 0.73. Adjusted for age and pre-pregnancy body mass index. The diamond represents the mean and the horizontal line represents the median

Fig. 2
Fig. 2

Changes in CCA IMT across pregnancy, adjusted for maternal age and pre-pregnancy BMI. Statistically significant differences are as follows: 1st Trimester vs. 1st Postpartum P = 0.03, 1st Trimester vs. 2nd Postpartum P = 0.01, 2nd Trimester vs. 1st Postpartum P = 0.01, 2nd Trimester vs. 2nd Postpartum P = 0.01. The diamond represents the mean and the horizontal line represents the median

Changes in weight, blood pressure, heart rate, lipid, glucose, and hsCRP concentrations followed expected patterns for healthy pregnancies [24] (Table 1). Greater weight was associated marginally with greater IAD, and attenuated the increase in IAD that occurred throughout pregnancy (Table 2, Model 3). When metabolic factors were considered, higher triglyceride concentrations were associated (P <  0.0001) with lower IAD, but higher hsCRP was associated (P = 0.0002) with greater IAD (Table 2, Model 5, and Table 3).
Table 2

Associationsa between inter-adventitial diameter, physical predictors, and significant metabolic predictors

Predictor

Unadjusted

Model 1b

Model 2b

 

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

Trimester 1

Ref

 

Ref

 

Ref

 

Trimester 2

0.361 (.07)c

0.0001

0.361 (.07)c

< 0.0001

0.389 (.07)c

< 0.001

Trimester 3

0.498 (.07)cd

0.0001

0.499 (.07)cd

< 0.0001

0.511 (.07)c

< 0.001

Postpartum

−0.015 (.05)

0.74

−0.014 (.05)

0.76

0.010 (.04)

0.81

Age (years)

  

−0.004 (.02)

0.81

−0.003 (.02)

0.83

Pre-pregnancy BMI (kg/m2)

  

0.046 (.02)

0.06

0.042 (.02)

0.09

SBP (mmHG)

    

0.004 (.00)

0.29

Predictor

Model 3b

Model 4b

Model 5b

 

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

Trimester 1

Ref

 

Ref

0.84

Ref

 

Trimester 2

0.294 (.09)c

0.001

0.321 (.09)c

< 0.001

0.456 (.07)c

< 0.0001

Trimester 3

0.338 (.13)c

0.009

0.392 (.14)c

0.008

0.683 (.12)cd

< 0.0001

Postpartum

−0.032 (.05)

0.49

−0.020 (.05)

0.69

− 0.029 (.04)

0.44

Age (years)

0.004 (.02)

0.82

− 0.001 (.02)

0.93

−0.006 (.02)

0.73

Pre-pregnancy BMI (kg/m2)

0.013 (.03)

0.67

0.047 (.02)

0.06

0.006 (.03)

0.85

Weight (kg)

0.015 (.01)

0.08

  

0.011 (.01)

0.12

Weight change (kg)

  

0.010 (.01)

0.29

  

Triglycerides (mg/dl)

    

−0.002 (.00)

< 0.0001

Log hsCRP (mg/L)

    

0.070 (.02)

0.0002

aLinear mixed models

bModel 1: Adjusted for age & pre-pregnancy BMI. Model 2: Model 1 plus SBP. Model 3: Model 1 plus weight. Model 4: Model 1 plus weight change. Model 5: Model 3 plus triglycerides and Log hsCRP

cDifferent from postpartum at p < .01. dDifferent from second trimester at p < .05

Weight change is from pre-pregnancy weight. β represents change in millimeters

Table 3

Associationsa of individual biomarkers with inter-adventitial diameter and common carotid artery intima-media thickness

Biomarker

Inter-adventitial Diameterb

Common Carotid Artery Intima-Media Thicknessb

β (SE)

P-value

β (SE)

P-value

Total Cholesterol (mg/dl)

−0.001 (0.1)

0.18

−0.000 (.00)

0.95

HDL-c (mg/dl)

0.002 (.00)

0.52

−0.000 (.00)

0.39

Triglycerides (mg/dl)

−0.001 (.00)

0.01

0.000 (.00)

0.45

LDL-c (mg/dl)

−0.001 (.00)

0.38

−0.000 (.00)

0.80

hsCRP (mg/L)

0.004 (.00)

0.03

0.000 (.00)

0.54

Fasting insulin (μU/ml)

0.004 (.01)

0.55

−0.002 (.00)

0.13

Fasting glucose (mg/dl)

−0.005 (.00)

0.13

−0.001 (.00)

0.09

Log HOMA-IR

−0.013 (.07)

0.86

−0.029 (.01)

0.02

aLinear mixed models

bModels include time point in pregnancy cycle (trimester or postpartum), age, pre-pregnancy BMI, systolic blood pressure, and weight change from pre-pregnancy baseline

β represents change in millimeters

Higher SBP was associated with greater CCA IMT; nonetheless, accounting for SBP did not attenuate the postpartum increase in CCA IMT (Table 4, Model 2). Greater weight gain was marginally associated with thinner CCA IMT (Table 4, Models 5, 6, 7), and greater IAD was associated with thicker CCA IMT (Table 4, Model 6). In addition, when metabolic factors were considered, greater HOMA-IR was associated with lower CCA IMT values (Table 4, Model 7). Accounting for HOMA-IR did not affect the increased CCA IMT observed postpartum (Table 4, Model 7).
Table 4

Associationsa between common carotid artery intima-media thickness, physical predictors, and significant metabolic predictors

Predictor

Unadjusted

 

Model 1b

Model 2b

Model 3b

 

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

Trimester 1

Ref

 

Ref

 

Ref

 

Ref

 

Trimester 2

0.001 (.01)

0.89

0.001 (.01)

0.89

0.002 (.01)

0.85

0.007 (.01)

0.56

Trimester 3

0.013 (.01)

0.24

0.013 (.01)

0.24

0.009 (.01)

0.43

0.022 (.02)

0.22

Postpartum

0.027 (.01)c

0.02

0.027 (.01) c

0.02

0.026 (.01)cd

0.03

0.031 (.01)c

0.01

Age (yr)

  

0.004 (.00)

0.03

0.004 (.00)

0.02

0.003 (.00)

0.08

Pre-pregnancy BMI (kg/m2)

  

−0.001 (.00)

0.78

−0.002 (.00)

0.45

0.000 (.00)

0.93

SBP (mm Hg)

    

0.001 (.00)

0.08

  

Weight (kg)

      

−0.000 (.00)

0.66

Predictor

Model 4b

Model 5 b

Model 6b

Model 7b

 

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

ß (SE)

P-value

Trimester 1

Ref

 

Ref

 

Ref

 

Ref

 

Trimester 2

0.016 (.01)

0.19

0.018 (.01)

0.17

0.007 (.01)

0.59

0.009 (.01)

0.51

Trimester 3

0.042 (.02)c

0.04

0.041 (.02)c

0.046

0.027 (.02)

0.19

0.033 (.02)c

0.13

Postpartum

0.036 (.01)d

0.003

0.035 (.01)d

0.005

0.034 (.01)c

0.006

0.027 (.01)d

0.03

Age (years)

0.002 (.00)

0.11

0.003 (.00)

0.07

0.003 (.002)

0.05

0.003 (.00)

0.12

Pre-pregnancy BMI (kg/m2)

−0.001 (.00)

0.70

−0.002 (.00)

0.35

−0.004 (.00)

0.15

−0.002 (.00)

0.55

Weight change (kg)

−0.002 (.00)

0.13

−0.002 (.00)

0.07

−0.002 (.00)

0.06

−0.002 (.00)

0.08

SBP (mmHg)

  

0.001 (.00)

0.04

0.001 (.00)

0.04

0.001 (.00)

0.03

Inter-adventitial diameter

    

0.026 (.01)

0.02

0.017 (.01)

0.17

Log HOMA-IR

      

−0.028 (.01)

0.03

aLinear mixed models

bModel 1: Adjusted for age & pre-pregnancy BMI. Model 2: Model 1 plus SBP. Model 3: Model 1 plus weight. Model 4: Model 1 plus weight change. Model 5: Model 1 plus SBP and weight change. Model 6: Model 5 plus inter-adventitial diameter. Model 7: Model 6 plus HOMA-IR

cDifferent from second trimester at p < .05. dDifferent from third trimester at p < .05

BMI is body mass index. SBP is systolic blood pressure. Weight change is from pre-pregnancy weight. β represents change in millimeters

Results of sensitivity analyses limited to women who completed all four initial visits and that excluded hsCRP outliers, were consistent with those from the primary analyses (Additional file 1: Table S1 and Additional file 2: Table S2). Moreover, for the second postpartum visit, no reproductive factors (e.g., number of interval pregnancies or breastfeeding status) were statistically significantly associated with either carotid measure (data not shown).

Discussion

Among our participants with normal first pregnancies, CCA IMT thickened late in pregnancy and remained thickened at 2.7 years postpartum; IAD, however, increased throughout pregnancy and returned to early pregnancy levels, postpartum. Although our results mirror those described in two classic studies [7, 8], our study is the first to follow women for more than 1 year postpartum. With more participants (i.e., 43) than those studies [7, 8] combined, our study establishes statistically significant changes in CCA IMT and IAD. While a recent study did not demonstrate that CCA IMT was increased in the 3rd trimester, it assessed women earlier in the trimester than we did [10]. Our results demonstrate that unhealthy change in CCA IMT is partially explained by changes in IAD and weight—not atherogenic metabolic changes.

An increase in CCA IMT beginning late in pregnancy and persisting postpartum beyond 2 years, in addition to lifestyle changes involved with parenthood and socio-economic profile of women with large families, could help explain the greater CVD risk that occurs for women of high parity [1, 3]. Greater IMT is a risk factor for CVD because thickened arteries are 1) less capable of responding to changes in blood pressure [25] and 2) more prone to atherosclerosis [26]. Although studies have identified greater CCA IMT in women of higher parity [6, 2729], the cause remains unknown. However, we observed thicker CCA IMT among our participants more than 2 years after childbirth, which suggests that the acute negative effect of pregnancy on CCA IMT may persist and could serve as a risk factor for CVD.

The observed changes in CCA IMT and IAD are consistent with the literature concerning hemodynamic changes in pregnancy and the effect of hemodynamic changes on arteries [3034]. Importantly, we provide serial measures in pregnancy to characterize this vascular remodeling and evaluate concomitant metabolic markers. Vascular remodeling is largely due to hemodynamic factors. Arterial walls adapt to maintain homeostasis between the two main stresses of blood flow: shear and tensile stress. First, shear stress is the frictional force of blood flowing along the arterial wall. Increased shear stress causes blood vessels to increase in diameter [3032]. Cardiac output increases early in the 1st trimester of pregnancy [33] and peaks at 30–60% above the non-pregnant level in the late 2nd or early 3rd trimester [33]. Increased cardiac output should increase IAD resulting from increased shear stress, as our results demonstrate. Second, tensile stress is the force of blood perpendicular to the arterial wall, and this force increases as arterial diameter increases, which causes arterial walls to thicken [30, 34]. CCA IMT would thicken during pregnancy as IAD increases, to normalize arterial wall stresses, as our results confirm [25].

In contrast to the effects of body weight and change in IAD, the metabolic changes during pregnancy that may be considered atherogenic in non-pregnant adults (i.e., increased total cholesterol, LDL-c, triglycerides, HOMA-IR, and hsCRP) do not explain the increased IAD and CCA IMT that we observed. As expected, we observed an association between higher hsCRP and greater IAD. Without pregnancy, higher hsCRP concentrations are associated with greater carotid IMT [3537], which is associated with greater IAD. However, in our study, hsCRP concentrations did not explain the observed changes in IAD. Our finding that higher triglyceride concentrations were associated with smaller IAD [12] was unexpected, because this relationship differs from that observed in non-pregnant adult women.

Triglyceride concentrations increase dramatically during healthy pregnancy to support fetal growth, and no accepted threshold value exists for what constitutes high triglyceride concentrations in pregnancy [24]. However, triglyceride concentrations can be excessive in pregnancy, as triglyceride concentrations in the upper percentiles have been associated with preeclampsia and preterm birth [3840]. Both high triglyceride concentrations and smaller IAD indeed could be associated with less healthy pregnancies. Our results suggest that paradigms of CVD prediction may not be applicable to the wellness state of pregnancy.

Our study benefited from the use of a highly valid and reproducible measure of carotid structure (i.e., B-mode ultrasonography), and high participant retention (i.e., 98%) in the initial study. We also collected serial vascular and biomarker measures during and after pregnancy, which strengthens this study, but the lack of pre-pregnancy measures poses a limitation. Limitations of the study are largely due to the rapidly changing hormonal and hemodynamic milieus of pregnancy and the postpartum period. Because the hemodynamic changes of pregnancy begin as early as 5 weeks of gestation [33], our 1st trimester values may not represent a true pre-pregnancy baseline. For example, thinning of the CCA IMT may have occurred before we could assess it. Similarly, because most participants (94%) were breastfeeding at the first postpartum visit, their hormonal and cardiovascular status had not attained new postpartum “normal” status. CCA IMT may regress after weaning. Our results also might not reflect those for women who formula-feed. Additionally, at the second postpartum visit, participants exhibited a varying number of subsequent pregnancies, which makes interpretation difficult. However, our results are consistent with those of the Cardiovascular Risk in Young Finns study, which found that young women who gave birth over a 6-year period had greater progression of CCA IMT than those who had not [6], and with epidemiologic studies showing greater CCA IMT in midlife women of higher parity [2729]. Moreover, although our largely white, well-educated participants do not represent all first-time pregnant women in the United States, our study provides valuable baseline data against which arterial remodeling in other demographic groups can be assessed.

Future work should follow a life course approach, and seek to enroll women during the preconception period to obtain a true baseline and then follow them through at least a several month period after weaning. Retention for the postpartum visits is critical. Additional studies should explore vascular adaptation to pregnancy in women in subsequent pregnancies, from different racial and ethnic groups, and with higher BMI. Collection of serum folate levels might provide valuable insights into the role folate deficiency during pregnancy plays in differences in vascular adaptation.

Conclusions

We found that IAD increased throughout a healthy first pregnancy and decreased by 8 weeks postpartum. In contrast, postpartum CCA IMT thickening persisted for more than 2 years. These adaptations can be explained—partially—by pregnancy-related changes in weight and IAD; moreover, they are not substantially explained by changes in metabolic measures. Therefore, our results suggest that pregnancy represents a unique setting of rapid physiologic changes that maintain homeostasis during a period of acute stress.

Understanding normal vascular adaptation to pregnancy can not only engender an improved understanding of the physiology of pregnancy complications, but also better identify women at risk for complications early in pregnancy. If it persists, the greater CCA IMT detected postpartum may help explain the higher CVD risk in women of higher parity.

Abbreviations

BMI: 

Body mass index

CCA IMT : 

Common carotid artery intima-media thickness

CVD : 

Cardiovascular disease

HDL-c : 

High density lipoprotein concentration

hsCRP : 

High-sensitivity C-reactive protein

IAD : 

Inter-adventitial diameter

LDL-c : 

Low density lipoprotein concentration

MVP : 

Maternal Vascular Adaptations to Healthy Pregnancy

SBP : 

Systolic blood pressure

SE : 

Standard error

URL : 

Ultrasound Research Laboratory

Declarations

Acknowledgments

The authors gratefully acknowledge William B. Greene, EdD, Scientific Editor and Writer at the University of Pittsburgh, School of Nursing, for his assistance with the preparation of this manuscript, and Alyssa Oakes, SN, for her assistance with development of the tables.

Funding

NAN was supported by NICHD grant T32HD0055162–04 and NHBLI grant T32HL083825 to the University of Pittsburgh. The project described was supported by the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005. The funding bodies had no role in design of the study; collection, analysis, and interpretation of data; or in writing the manuscript.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

NAN performed the original study visits; analyzed the data; and wrote the first, second, and third drafts of the manuscript. MB provided statistical support, contributed to interpretation of results, and read and approved the final manuscript. JC contributed to interpretation of results, and read and approved the final manuscript. MD designed the follow up study, performed study visits, and read and approved the final manuscript. CKM designed the original study, contributed to interpretation of results, and read and approved the final manuscript. JMR contributed to interpretation of results, and read and approved the final manuscript. AS contributed to interpretation of results and read and approved the final manuscript. PGT provided statistical support, contributed to interpretation of results, and read and approved the final manuscript. EBM contributed to interpretation of results, and read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the University of Pittsburgh, Human Research Protection Office, ID # PRO09050089 and ID# PRO14060316. This body approved an informed consent document that was signed by all study participants.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 De Soto Street, Pittsburgh, PA 15261, USA
(2)
Department of Health Promotion and Development, School of Nursing, University of Pittsburgh, 3500 Victoria Street, 440 Victoria Building, Pittsburgh, PA 15261, USA
(3)
Department of Obstetrics and Gynecology, School of Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15213, USA
(4)
Department of Clinical and Translational Research, School of Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15213, USA
(5)
Magee-Womens Research Institute, Magee-Womens Hospital of University of Pittsburgh Medical Center (UPMC), 204 Craft Avenue, Pittsburgh, PA 15213, USA

References

  1. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159(2):215–21. e216View ArticlePubMedGoogle Scholar
  2. Bertuccio P, Tavani A, Gallus S, Negri E, La Vecchia C. Menstrual and reproductive factors and risk of non-fatal acute myocardial infarction in Italy. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):67–72.View ArticlePubMedGoogle Scholar
  3. Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, Stunkard AJ, D'Agostino RB. Number of pregnancies and the subsequent risk of cardiovascular disease. NEnglJMed. 1993;328(21):1528–33.View ArticleGoogle Scholar
  4. Ness RB, Schotland HM, Flegal KM, Shofer FS. Reproductive history and coronary heart disease risk in women. EpidemiolRev. 1994;16(2):298–314.Google Scholar
  5. Akhter T, Larsson A, Larsson M, Wikstrom AK, Naessen T. Artery wall layer dimensions during normal pregnancy: a longitudinal study using noninvasive high-frequency ultrasound. Am J Physiol Heart Circ Physiol. 2013;304(2):H229–34.View ArticlePubMedGoogle Scholar
  6. Skilton MR, Bonnet F, Begg LM, Juonala M, Kahonen M, Lehtimaki T, Viikari JS, Raitakari OT. Childbearing, child-rearing, cardiovascular risk factors, and progression of carotid intima-media thickness: the cardiovascular risk in young Finns study. Stroke. 2010;41(7):1332–7.View ArticlePubMedGoogle Scholar
  7. Mersich B, Rigo J Jr, Besenyei C, Lenard Z, Studinger P, Kollai M. Opposite changes in carotid versus aortic stiffness during healthy human pregnancy. ClinSci(Lond). 2005;109(1):103–7.Google Scholar
  8. Visontai Z, Lenard Z, Studinger P, Rigo J Jr, Kollai M. Impaired baroreflex function during pregnancy is associated with stiffening of the carotid artery. Ultrasound ObstetGynecol. 2002;20(4):364–9.Google Scholar
  9. Sator MO, Joura EA, Gruber DM, Obruca A, Zeisler H, Egarter C, Huber JC. Non-invasive detection of alterations of the carotid artery in pregnant women with high-frequency ultrasound. Ultrasound ObstetGynecol. 1999;13(4):260–2.Google Scholar
  10. Iacobaeus C, Andolf E, Thorsell M, Bremme K, Jorneskog G, Ostlund E, Kahan T. Longitudinal study of vascular structure and function during normal pregnancy. Ultrasound Obstet Gynecol. 2017;49(1):46–53.View ArticlePubMedGoogle Scholar
  11. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111. quiz 189-190View ArticlePubMedGoogle Scholar
  12. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke. 1996;27(4):654–60.View ArticlePubMedGoogle Scholar
  13. Polak JF, Wong Q, Johnson WC, Bluemke DA, Harrington A, O'Leary DH, Yanez ND. Associations of cardiovascular risk factors, carotid intima-media thickness and left ventricular mass with inter-adventitial diameters of the common carotid artery: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2011;Google Scholar
  14. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med. 1994;236(1):79–84.View ArticlePubMedGoogle Scholar
  15. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107(1):139–46.View ArticlePubMedGoogle Scholar
  16. Eigenbrodt ML, Sukhija R, Rose KM, Tracy RE, Couper DJ, Evans GW, Bursac Z, Mehta JL. Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. CardiovascUltrasound. 2007;5:11.Google Scholar
  17. Kozakova M, Morizzo C, La Carrubba S, Fabiani I, Della Latta D, Jamagidze J, Chiappino D, Di Bello V, Palombo C. Associations between common carotid artery diameter, Framingham risk score and cardiovascular events. Nutr Metab Cardiovasc Dis. 2017; 27(4):329–34.Google Scholar
  18. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol. 1991;11(6):565–77.View ArticlePubMedGoogle Scholar
  19. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.View ArticlePubMedGoogle Scholar
  20. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMedGoogle Scholar
  21. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476–82.PubMedGoogle Scholar
  22. Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;20(5):586–90.PubMedGoogle Scholar
  23. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.View ArticlePubMedGoogle Scholar
  24. Liu LX, Arany Z. Maternal cardiac metabolism in pregnancy. Cardiovasc Res. 2014;101(4):545–53.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Carallo C, Irace C, Pujia A, De Franceschi MS, Crescenzo A, Motti C, Cortese C, Mattioli PL, Gnasso A. Evaluation of common carotid hemodynamic forces. Relations with wall thickening. Hypertension. 1999;34(2):217–21.View ArticlePubMedGoogle Scholar
  26. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107(3):490–7.View ArticlePubMedGoogle Scholar
  27. Humphries KH, Westendorp IC, Bots ML, Spinelli JJ, Carere RG, Hofman A, Witteman JC. Parity and carotid artery atherosclerosis in elderly women: the Rotterdam study. Stroke. 2001;32(10):2259–64.View ArticlePubMedGoogle Scholar
  28. Wolff B, Volzke H, Robinson D, Schwahn C, Ludemann J, Kessler C, John U, Felix SB. Relation of parity with common carotid intima-media thickness among women of the study of health in Pomerania. Stroke. 2005;36(5):938–43.View ArticlePubMedGoogle Scholar
  29. Skilton MR, Serusclat A, Begg LM, Moulin P, Bonnet F. Parity and carotid atherosclerosis in men and women: insights into the roles of childbearing and child-rearing. Stroke. 2009;40(4):1152–7.View ArticlePubMedGoogle Scholar
  30. Pries AR, Reglin B, Secomb TW. Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Hypertension. 2005;46(4):725–31.View ArticlePubMedGoogle Scholar
  31. Herity NA, Ward MR, Lo S, Yeung AC. Review: clinical aspects of vascular remodeling. J Cardiovasc Electrophysiol. 1999;10(7):1016–24.View ArticlePubMedGoogle Scholar
  32. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol. 1999;19(6):1491–8.View ArticlePubMedGoogle Scholar
  33. Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. IntJCardiol. 2005;98(2):179–89.Google Scholar
  34. Bokov P, Chironi G, Orobinskaia L, Flaud P, Simon A. Carotid circumferential wall stress homeostasis in early remodeling: theoretical approach and clinical application. J Clin Ultrasound. 2012;40(8):486–94.View ArticlePubMedGoogle Scholar
  35. Toprak A, Kandavar R, Toprak D, Chen W, Srinivasan S, Xu JH, Anwar A, Berenson GS. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa heart study). BMC Cardiovasc Disord. 2011;11:78.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B, Falcone VA, Quaranta VN, Ventura VA, Zucano A, Di Serio F, et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules. 2014;19(2):1651–62.View ArticlePubMedGoogle Scholar
  37. Ock SY, Cho KI, Kim HJ, Lee NY, Kim EJ, Kim NK, Lee WH, Yeo GE, Heo JJ, Han YJ, et al. The impacts of C-reactive protein and atrial fibrillation on carotid atherosclerosis and ischemic stroke in patients with suspected ischemic cerebrovascular disease: a single-center retrospective observational cohort study. Korean Circ J. 2013;43(12):796–803.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG. 2013;120(11):1321–32.View ArticlePubMedGoogle Scholar
  39. Mudd LM, Holzman CB, Catov JM, Senagore PK, Evans RW. Maternal lipids at mid-pregnancy and the risk of preterm delivery. Acta Obstet Gynecol Scand. 2012;91(6):726–35.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, Roberts JM. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197(6):610 e611–7.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement